We have recently expanded our dedicated, world-class cardiac surgery program.
Robbin Cohen, MD, MMM, has joined the team of Cedars-Sinai physicians at Huntington Health as director of the cardiac surgery program.
This development brings Cedars-Sinai’s top-ranked cardiac surgery program to patients throughout the San Gabriel Valley.
TAVR – Minimally Invasive Valve Replacement
We are committed to providing our community with leading-edge cardiology care, including the groundbreaking and minimally-invasive TAVR (transcatheter aortic valve replacement) procedure.
Read more about the TAVR procedure below, or call (626) 397-2523 with any questions.
Leading the TAVR team at Huntington Hospital, Dr. Azhil (Alex) Durairaj, MD, interventional cardiologist, and Robbin Cohen, MD, medical director for cardiothoracic surgery (pictured), were the first in the San Gabriel Valley to perform the less invasive TAVR procedure.
WATCHMAN – Stroke Risk Treatment
Huntington Hospital is the only facility in the San Gabriel Valley to offer the FDA-approved WATCHMAN™ Left Atrial Appendage Closure (LAAC) device for patients with atrial fibrillation (AFib) as an alternative to the lifelong use of warfarin or novel oral anticoagulants (NOAC) for people with AFib not caused by a heart valve problem (also known as non-valvular AFib).
“The WATCHMAN device is a novel alternative for patients with non-valvular AFib at risk for a stroke, especially those with a compelling reason not to be on blood thinners. We provide over 2,000 catheterizations and electrophysiology procedures, and 42,000 non-invasive cardiac diagnostic procedures each year. I’m proud to now offer this safe and effective procedure to our patients seeking stroke risk treatment.”Alex Durairaj, MD, medical director of Cardiovascular Services, Huntington Hospital.
Learn about WATCHMAN
FlowTriever® – Lifesaving Blood Clot Remover
Huntington Hospital was the first community-based hospital in the greater Los Angeles area to use FlowTriever® for the treatment of pulmonary embolism. The FlowTriever® is the first mechanical thrombectomy device FDA-indicated and purpose-built for the treatment of pulmonary embolism, removing large clots from big vessels such as the pulmonary arteries without the need for thrombolytic drugs and consequent ICU stay.
A pulmonary embolism is caused when blood clots break free in the deep veins of the body and travel through the venous system to become lodged in the pulmonary arteries. The blockage of blood flow results in right heart strain as the right ventricle is unable to push blood past the clot. In severe cases, right heart failure may occur leading to a fatal event.
The FlowTriever® procedure is typically a one-hour, single-session procedure, performed under conscious sedation. The device’s mechanism of action is to disrupt and aspirate a clot using nitinol mesh disks and large lumen aspiration Triever® catheters to rapidly remove the clot and restore blood flow. Find a cardiologist affiliated with Huntington Hospital.